Get started
Award

R01 AG025516

Funded outputs count: 42
Funder award ID: R01 AG025516
OpenAlex ID: G10563324
Association of age with clinical progression across plasma p-tau217 levels
2026 · Ruyu Shi, Lamia T. Choity, et al. · medRxiv
PDF
Development of a Novel Blood‐Based Assay for Brain‐Derived Tau and Its Validation in Traumatic Brain Injury
2026 · Wasiu G. Balogun, Xuemei Zeng, et al. · Journal of Neurochemistry · 1
The dangers of data double dipping in assessing the classification accuracies of blood biomarkers in Alzheimer’s disease and related disorder research
2026 · Tianshu Liu, Xuemei Zeng, et al. · medRxiv
PDF
CNS-selective plasma p-tau217 accurately captures Alzheimer’s disease pathology and progression
2026 · Xuemei Zeng, Marissa F. Farinas, et al. · medRxiv · 2
PDF
2‐aminobutyrate mediates the impact of air pollution on blood biomarkers of Alzheimer's disease
2026 · Anum Saeed, Chris Mckennan, et al. · Alzheimer s & Dementia
Plasma amyloid-β predicts amyloid-β accumulation in PET A- non-demented participants
2026 · Alexandra Gogola, Ann D. Cohen, et al. · Journal of Alzheimer s Disease · 2
Plasma brain-derived tau: analytical and clinical validation of the first commercial immunoassay
2026 · Michel N. Nafash, Sarah E. Svirsky, et al. · Scientific Reports · 7
PDF
Head-to-head comparison of plasma p-tau217 immunoassays for incipient Alzheimer’s disease in community cohorts
2026 · Rebecca A. Deek, Wasiu G. Balogun, et al. · Alzheimer s Research & Therapy · 2
Streamlined resource-efficient plasma amyloid-beta mass spectrometry assay has improved biomarker performance in preclinical Alzheimer’s disease
2026 · Yijun Chen, Xuemei Zeng, et al. · Nature Communications · 11
PDF
Plasma biomarkers, brain amyloid‐beta pathology, and cortical thickness in a non‐Hispanic White and Black/African American middle‐aged community cohort: The HCP‐CoBRA study
2025 · Shayna T. Brodman, Nicholas Heaton, et al. · Alzheimer s & Dementia · 1
PDF
Cross‐cohort validation and cutpoint estimation of the Janssen plasma p‐tau217+ assay in predominantly cognitively normal community studies
2025 · Wasiu G. Balogun, Xuemei Zeng, et al. · Alzheimer s & Dementia · 2
PDF
Association Between the Genetic Risk for Attention-Deficit/Hyperactivity Disorder and Cognitive Function in Older Age: The MYHAT Population-Based Study
2025 · Douglas Teixeira Leffa, Yingjin Zhang, et al. · American Journal of Geriatric Psychiatry · 3
PDF
CSF total tau as a proxy of synaptic degeneration
2025 · Carolina Soares, Bruna Bellaver, et al. · Nature Communications · 15
PDF
Arterial stiffness moderates the link between NfL and cognition: The IGNITE study
2025 · Amani M. Norling, Lewis A. Lipsitz, et al. · Alzheimer s & Dementia · 7
PDF
Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort
2025 · Menayit Tamrat Dresse, Pamela C. L. Ferreira, et al. · Alzheimer s Research & Therapy · 10
PDF
Equivalence of Plasma and Serum for Clinical Measurement of p‐tau217: Comparative Analyses of Four Blood‐Based Assays
2025 · Yijun Chen, Ally L. Albert, et al. · Journal of Neurochemistry · 18
PDF
Pittsburgh plasma p‐tau217: Classification accuracies for autosomal dominant and sporadic Alzheimer's disease in the community
2025 · Anuradha Sehrawat, Xuemei Zeng, et al. · Alzheimer s & Dementia · 8
PDF
NIAGADS: A data repository for Alzheimer's disease and related dementia genomics
2025 · Amanda Kuzma, Otto Valladares, et al. · Alzheimer s & Dementia · 7
PDF
Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
2025 · Akihiro Kitani, Yusuke Matsui, et al. · Alzheimer s Research & Therapy · 5
PDF
Tau Imaging: Use and Implementation in New Diagnostic and Therapeutic Paradigms for Alzheimer’s Disease
2025 · Alexandra Gogola, Brian J. Lopresti, et al. · Geriatrics · 3
PDF
Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis
2025 · Maulikkumar Patel, Cyril Pottier, et al. · Human Molecular Genetics · 2
Effect of blood collection tube containing protease inhibitors on the pre‐analytical stability of Alzheimer's disease plasma biomarkers
2024 · Yijun Chen, Xuemei Zeng, et al. · Journal of Neurochemistry · 15
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
2024 · Fernando Gonzalez-Ortiz, Bjørn-Eivind Kirsebom, et al. · Nature Communications · 84
PDF
Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates
2024 · Tohidul Islam, Hlin Kvartsberg, et al. · Alzheimer s & Dementia · 9
Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
2024 · Przemysław R. Kac, Fernando González-Ortiz, et al. · Nature Communications · 49
PDF
Year
Topic